Effect of PEAR1 Genetic Variants on 1-Year Outcomes in Chinese Patients with Acute Myocardial Infarction After Percutaneous Coronary Intervention
Authors:
Open Access
- 1 May 2018
- journal article
- research article
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 25 (5) , 454-459
Abstract
Aims: Platelet endothelial aggregation receptor-1 (PEAR1) is a platelet transmembrane protein that plays an important role on platelet aggregation. The aim of this study was to investigate whether PEAR1 genetic variations are associated with 1-year outcomes in Chinese patients with acute myocardial infarction after percutaneous coronary intervention. Methods: A total of 647 consecutive Chinese patients with acute myocardial infarction that underwent percutaneous coronary intervention and that were exposed to standard dual antiplatelet therapy with aspirin and clopidogrel were enrolled in this study. Six single nucleotide polymorphisms of PEAR1 were detected using the ligase detection reaction method. The follow-up period was 12 months. Results: Overall, 66 (10.2%) adverse ischemic events occurred. Multivariate Cox regression analysis showed that carriage of the PEAR1 rs56260937 minor allele was an independent predictor of revascularization events (OR=2.15, 95% CI 1.12-4.15, p=0.022) after adjusting for confounding factors. Conclusions: Genetic testing for PEAR1 variants can be helpful in predicting adverse ischemic events in Chinese patients with acute myocardial infarction after percutaneous coronary intervention.Keywords
This publication has 19 references indexed in Scilit:
- Targeted Deep Resequencing Identifies Coding Variants in the PEAR1 Gene That Play a Role in Platelet AggregationPLOS ONE, 2013
- Genetic Variation in PEAR1 Is Associated With Platelet Aggregation and Cardiovascular OutcomesCirculation: Cardiovascular Genetics, 2013
- Antiplatelet and Antithrombin Strategies in Acute Coronary Syndrome: State-Of-The-Art ReviewCurrent Cardiology Reviews, 2012
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionCirculation, 2011
- Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin useAmerican Heart Journal, 2011
- Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)European Heart Journal, 2010
- A Novel Variant in the Platelet Endothelial Aggregation Receptor-1 Gene Is Associated With Increased Platelet AggregabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Novel targets for antithrombotic drug discoveryBlood Cells, Molecules, and Diseases, 2006
- Platelet Endothelial Aggregation Receptor 1 (PEAR1), a Novel Epidermal Growth Factor Repeat-containing Transmembrane Receptor, Participates in Platelet Contact-induced ActivationJournal of Biological Chemistry, 2005